AstraZeneca Scraps Plan To Expand Vaccine Plant In UK

AstraZeneca cancels UK plant after subsidies cut
BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million (S$756.9 million) vaccine plant, a major blow to the Labour government’s plans to revive a sluggish economy.
AstraZeneca ditches plan to build new UK vaccine plant
AstraZeneca is pulling out of its plans to build a £450mn UK vaccine manufacturing plant after months of wrangling with British officials about state investment for the Merseyside project, in a major blow to Prime Minister Sir Keir Starmer’s government.
AstraZeneca Scraps Speke Vaccine Plant Plans
AstraZeneca announced it will not proceed with plans for a 450 million pound vaccine manufacturing plant in Speke, Liverpool. The decision was influenced by discussions with the current government and changes in the financial offer.
AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government
Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England.
AstraZeneca scraps £450m vaccine plant after Labour funding cut
AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government.
AstraZeneca blames Labour as it ditches plan to build £450m UK vaccine plant
AstraZeneca has dropped its plans to £450m at its vaccine manufacturing plant in Speke, Merseyside, blaming a reduction in government support. The move will be seen as a major blow to the government, coming at a time when it is pushing hard to secure investment in the UK to drive economic growth.
AstraZeneca scraps $558 mn UK investment plans citing cut in govt support
The decision to ditch the development of an existing facility in the Speke area of Liverpool comes at a time when Prime Minister Keir Starmer is pushing hard to drum up investment in Britain
AstraZeneca ditches £450m investment in UK plant
AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Liverpool, blaming a reduction in government support. The pharmaceutical giant has announced its decision just two days after Chancellor Rachel Reeves set out Labour's plan to go "further and faster" to boost economic growth.
Fresh blow for Rachel Reeves as AstraZeneca scraps £450m investment in UK vaccine plant
Fresh blow for Rachel Reeves as AstraZeneca scraps £450m investment in UK vaccine plant - The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer but the cancell
AstraZeneca ditches UK investment over cut in government support
AstraZeneca will no longer invest 450 million pounds ($558.3 million) at its vaccine manufacturing plant in northern England, the company said on Friday, citing a reduction in government support. The
AstraZeneca cancels £450m investment in UK after dispute over Government support
The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer of help for the Merseyside investment.
AstraZeneca cancels £450m vaccine plant in UK after Government 'own goal' in blow to Rachel Reeves growth plan
AstraZeneca cancels £450m vaccine plant in UK after Government 'own goal' in blow to Rachel Reeves growth plan - The ...
brudirect1h
Blow For Reeves As Astrazeneca Ditches £450m Investment
Blow For Reeves As Astrazeneca Ditches £450m Investment. AstraZeneca. February 2nd, 2025 \| 00:11 AM \| 154 views. WORLD BUSINESS. AstraZenec ...
AstraZeneca abandons £450m vaccine factory in blow to Reeves
AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start ...
The Pharma Letter12h
BRIEF—AstraZeneca ditches £450 million UK investment
UK pharma major AstraZeneca has scrapped its plans to invest £450 million in expanding ($559 million) to expand its vaccine plant in Speke, Liverpool, blaming a reduction in government support.
AstraZeneca cancels £450m UK investment after dispute over Government support
Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous ...